新开河品牌怎么样 申请店铺

我要投票 新开河在人参行业中的票数:569 更新时间:2025-11-22
新开河是哪个国家的品牌?「新开河」是 康美药业股份有限公司 旗下著名品牌。该品牌发源于吉林省通化市,由创始人马董在1997年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力新开河品牌出海!将品牌入驻外推网,定制新开河品牌推广信息,可以显著提高新开河产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

新开河怎么样

成立于1997年,较早布局中医药全产业,以中药饮片为核心,以智慧药房为抓手,打造大健康+大平台+大数据+大服务体系


康美药业股份有限公司(600518)成立于1997年,于2001年在上交所上市。公司秉承“心怀苍生、大爱无疆”的核心价值观和“用爱感动世界、用心经营健康”的经营理念,在国家振兴中医药事业战略指引下,较早布局中医药全产业,以中药饮片为核心,以智慧药房为抓手,打造“大健康+大平台+大数据+大服务”体系,成为中医药全产业链服务型“智慧+”大健康产业上市企业。

康美药业上至药材种植、药材交易,下至生产开发、终端销售,已基本贯穿中医药产业链的上、中、下游产业,业务渗透中医药全产业链的各个关键环节,有效地整合全产业链资源。公司先后在全国各地投资建立140多家涵盖药材种植、中药材交易市场、现代物流中心和产业基地等业务的企业。

在全国建立了17个中药饮片和医药现代化生产基地,与超过2000家医疗机构、20万家药店建立了合作关系,年门诊总量达到2.5亿人次以上,投资管理康美医院、康美梅河口中心医院、康美通辽医院、康美开原市中心医院、康美通城人民医院、康美柳河中心医院等多家公立医院,在100多家公立医院开展医药物流延伸配送服务。

公司以国家中医药管理局信息化医疗服务平台试点单位为契机,把互联网深度布局全产业链中,以中药饮片为核心,以智慧药房为抓手,围绕“大健康+大平台+大数据+大服务”体系,以全产业链资源优势,积极探索中医药工业智能制造4.0,较早打造“智慧药房”模式。“智慧药房”模式上升为行业标准,为患者提供了“一站式”药事服务。截止2018年三季度,康美智慧药房累计处方量710万张,服务患者250万人,实现了“让信息多跑路,让群众少跑腿”。

康美药业丰富的医疗资源为公司以互联网思维、技术,改造和升级传统医疗健康产业,打造具有优良用户体验、覆盖全生命周期、一站式完整医疗服务闭环的移动健康管理大平台,奠定了坚实的基础。


Founded in 1997, Kangmei Pharmaceutical Co., Ltd. (600518) was founded in 1997 and listed on the Shanghai Stock Exchange in 2001. It has an early layout of the whole industry of traditional Chinese medicine, with herbal pieces as the core and smart pharmacies as the starting point to build a big health + big platform + big data + big service system. The company adheres to the core values of "caring for the world, loving the boundless" and the business philosophy of "moving the world with love and managing health with heart". Under the guidance of the national strategy of rejuvenating the cause of traditional Chinese medicine, the whole industry of traditional Chinese medicine is laid out earlier, with Chinese herbal pieces as the core and smart pharmacies as the starting point, and the system of "big health + big platform + big data + big service" is built to become the whole industry of traditional Chinese medicine Chain service-oriented "wisdom +" large health industry listed enterprises. Kangmei pharmaceutical industry has basically run through the upstream, midstream and downstream industries of TCM industry chain from the planting and trading of medicinal materials to the production and development and terminal sales. Its business penetrates all key links of the whole industry chain of TCM and effectively integrates the resources of the whole industry chain. The company has successively invested and established more than 140 enterprises covering medicine planting, Chinese medicine trading market, modern logistics center and industrial base. It has established 17 modern production bases of Chinese herbal pieces and medicine, established cooperative relations with more than 2000 medical institutions and 200000 pharmacies, with an annual outpatient volume of more than 250 million person times, invested and managed many hospitals, including Kangmei hospital, Kangmei Meihekou Central Hospital, Kangmei Tongliao hospital, Kangmei Kaiyuan Central Hospital, Kangmei Tongcheng people's Hospital and Kangmei Liuhe central hospital Public hospitals, in more than 100 public hospitals to carry out pharmaceutical logistics extended distribution services. Taking the opportunity of the pilot unit of the informatization medical service platform of the State Administration of traditional Chinese medicine, the company takes the Internet as an in-depth layout in the whole industry chain, with Chinese herbal pieces as the core, smart pharmacy as the starting point, around the "big health + big platform + big data + big service" system, and with the resource advantages of the whole industry chain, actively explores the intelligent manufacturing 4.0 of the traditional Chinese medicine industry, and builds the "smart pharmacy" model earlier Type. The mode of "smart pharmacy" has risen to the industry standard, providing patients with "one-stop" pharmaceutical services. As of the third quarter of 2018, Kangmei smart pharmacy has accumulated 7.1 million prescriptions, served 2.5 million patients, and realized "let more information run more, let the masses run less". Kangmei pharmaceutical's rich medical resources have laid a solid foundation for the company to transform and upgrade the traditional medical and health industry with internet thinking and technology, and to build a mobile health management platform with excellent user experience, covering the whole life cycle and one-stop complete medical service closed-loop.

本文链接: https://brand.waitui.com/f1e75a350.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

《大型网络平台个人信息保护规定(征求意见稿)》公开征求意见

36氪获悉,国家互联网信息办公室、公安部就《大型网络平台个人信息保护规定(征求意见稿)》公开征求意见。征求意见稿提出,大型网络平台服务提供者应当将在中华人民共和国境内运营中收集和产生的个人信息存储在境内。确需向境外提供的,应当符合国家数据出境安全管理有关规定。大型网络平台服务提供者应当按照国家有关规定,健全个人信息出境安全相关技术和管理措施,及时防范、处置个人信息违法违规出境安全风险和威胁。

2小时前

宁德时代与上汽商用车达成深度战略合作

36氪获悉,11月22日,据宁德时代微信公众号,在第21届广州国际车展上,宁德时代与上汽商用车正式宣布达成深度战略合作。双方将围绕“技术共研、生态共建、全球共进”三大方向,在商用车新能源化、智能化领域全面深化合作,共同构建“车、电、站、云”一体化的智慧换电生态与绿色运力体系。

2小时前

北京“十四五”期间企业直接融资超5.6万亿元

据新华社,记者从日前举行的首都“十四五”规划高质量收官系列主题新闻发布会金融业发展成就专场上获悉,“十四五”期间,北京地区多元化融资渠道进一步拓宽,企业实现直接融资超5.6万亿元。金融“五篇大文章”合计贷款余额6.8万亿元,高于人民币各项贷款增速2.1个百分点,为首都经济持续向好和高质量发展营造良好的金融环境。(新华网)

2小时前

李斌:乐道也将有右舵车型

36氪获悉,11月21日,蔚来创始人李斌表示:乐道接下来也会有右舵车型,它需要时间。 今年11月18日,蔚来旗下高端小车品牌萤火虫的右舵车型正式量产,首批将发运至新加坡市场。未来,乐道也将推出右舵车型。

2小时前

鸭绒价格近期仍在高位 中下游追单采购意愿活跃

财联社记者从业内了解到,羽绒服目前进入消费旺季,“(白鸭绒价)10月份几乎是一天一个价,这段时间没有在涨,维持在高位。”尽管多数企业认为当前的原料价格偏高,但由于前期备货不足,促使中下游的追单采购意愿保持活跃。上市公司方面,记者采访获悉华英农业羽绒加工产能满产;古麒绒材当前整体羽绒产能2288吨,公司具备一定数量的鸭绒和鹅绒库存,随着羽绒价格上涨,公司库存相应增值。(财联社)

2小时前

本页详细列出关于新开河的品牌信息,含品牌所属公司介绍,新开河所处行业的品牌地位及优势。
咨询